echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > In 2022, a large number of pharmaceutical companies will accelerate their exit!

    In 2022, a large number of pharmaceutical companies will accelerate their exit!

    • Last Update: 2022-08-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [Pharmaceutical Network Industry News] On May 17, the Jinan Administrative Examination and Approval Service Bureau issued an announcement on the cancellation of the "Drug Business License" (Retail) (.
    20220022), according to relevant regulations, including Shandong Zhiyaotang Pharmaceutical Chain .
    , L.
    , Jinan Furenmei Pharmacy Chain .
    , L.
    forty-first branch, Shandong Yanghetang Pharmaceutical Chain .
    , L.
    Nankang Road Store, Shandong Yanghetang Pharmaceutical Chain .
    , L.
    Baihua Mingdu Store, Shandong Yanghetang Pharmaceutical Chain .
    , L.
    Ten The five pharmacies in the seven branches meet the conditions for cancellation of the "Drug Business License", and the bureau cancels their "Drug Business License" according to the l.
    On the same day, the announcement (.
    20220006) of the cancellation of the "Drug Business License" in Tongzhou District, Nantong City was releas.
    The application for cancellation of the "Drug Distribution License" and related materials were review.
    After research and decision, it is agreed to cancel the "Drug Business License" of the above-mentioned units according to law, which is hereby announc.
    On May 10, the Liaoning Provincial Food and Drug Administration issued an announcement on the cancellation of the "Drug Business License" (Liaoning Drug Administration Report [2022] .

    2
    In accordance with relevant regulations and according to the application of the enterprise, the bureau decided to cancel the "Drug Business License" of Liaoning Yaoduoduo Pharmacy Chain .

    , L.

    in accordance with the l.

    On May 7, the Hainan Provincial Food and Drug Administration issued an announcement (.

    3, 2022) on the cancellation of the "Drug Business License" of Hainan Wankang Pharmaceutical .

    , L.

    The company decided to terminate the drug business for its own reasons and applied for the cancellation of " According to the relevant regulations, the bureau agreed to cancel the company's "Drug Business Licens.

    On May 5, the Municipal Supervision Bureau of Lianping County, Heyuan City, Guangdong Province issued an announcement to cancel the "Drug Business Licens.

    According to the announcement, according to relevant regulations, as of May 5, 2022, the bureau has cancelled the "Drug Business License" of Lianping County Zhiyuntang Pharmaceutical .

    , L.

    in accordance with the l.

    Judging from the reasons for cancellation, it is an application for an enterpri.

    Judging from the information released by local municipal regulatory bureaus since 2022, a large number of pharmaceutical companies are accelerating their ex.

    Not only local pharmaceutical companies, but also some foreign-funded subsidiaries are also leaving the mark.

    For example, on March 15, the Jiangsu Provincial Food and Drug Administration issued an announcement saying that after a written application by Bristol-Myers Squibb (China) Pharmaceutical .

    , L.

    , the bureau decided to cancel it according to relevant regulatio.

    The company's "pharmaceutical business licens.

    Judging from the reasons for cancellation, it is mainly based on enterprise applications, of course, there are also enterprises that have been cancelled due to expired certificat.

    For example, at the end of January 2022, the Lianjiang Municipal Supervision Bureau of Guangdong Province cancelled the "Drug Business Licenses" of 121 enterprises according to law, of which 108 pharmacies were cancelled due to expired certificates, accounting for 83% of the tot.

    According to the "Drug Administration Law" and the "Measures for the Supervision and Administration of Drug Circulation", to engage in drug wholesale activities, relevant approvals should be obtained and a drug business license should be obtain.

    Without a drug business license, no drug business shall be allow.

    The cancellation of the certificates of these pharmaceutical companies means that they will no longer be able to conduct drug sales busine.

    Behind the cancellation of certificates of a large number of pharmaceutical companies, the industry believes that there is a close relationship with the pharmaceutical market environme.

    In recent years, with the normalization of centralized procurement, the product structure of the market has chang.

    It is expected that in the future, more and more pharmaceutical companies will cancel the approval documents that have not been sold for a long time, and cancel the drug business licen.

     
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.